19,500 residents in Olongapo City get jabs vs COVID-19 | Inquirer News

19,500 residents in Olongapo City get jabs vs COVID-19

OLONGAPO CITY — Over 19,500 residents in the city have already been vaccinated against COVID-19 but the number remained still far below the target population for herd immunity, an official said on Friday, July 2.

Mayor Rolen Paulino Jr. said only 4,500 of this number had received their second dose or were already fully vaccinated, which reflected only 3.2 percent of the target 140,000 vaccine recipients.

He said hitting the city’s target was at snail’s pace due to the limited supply of vaccines coming from the national government.

Article continues after this advertisement

About 6,000 of the inoculated residents are senior citizens while the rest are health workers and those with comorbidities.

FEATURED STORIES

Early this week, the city has also started accommodating overseas Filipino workers (OFWs), including seafarers, in its vaccine rollout.

Paulino said OFWs who are scheduled to leave the country in the next four months could avail of the vaccine.

JPV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Olongapo City

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.